SlideShare a Scribd company logo
1 of 20
Pharmaceutical Excipients &
Formulation of a Dosage Form
Presented by Md. Faysal Id: 151-29-760
Cellulose acetate
 Non-proprietary name: BP : Cellulose acetate
USP : Cellulose acetate
 Chemical name: Cellulose acetate , Cellulose diacetate ,
Cellulose triacetate.
 Structure formula: C164H174O111
 Functional category:
 Coating agent
 Extended release agent
 Tablet and capsule diluent
 Application in pharmaceutical formulation:
 Used as a semipermeable coating on tablets.
 Used in transdermal drug delivery systems.
 Highly absorbent and resistant to moderate temperature.
 They don’t shrink or wrinkle.
 Stability and storage conditions:
 Stable if stored in a well-closed container in a cool, dry place .
 Incompatibilities:
 Incompatible with strongly acidic or alkaline substances.
Cellulose Acetate Phthalate
 Non-proprietary Name:
BP: Cellacefate
USP: Cellacefate
 Chemical Name:
Cellulose, acetate, 1,2-benzenedicarboxylate
 Structural Formula:
 Functional Category : Coating agent
 Applications in Pharmaceutical Formulation:
 Used as an enteric film coating material.
 Used as a matrix binder for tablets and capsules.
 Commonly applied to solid-dosage forms.
 Stability and Storage Conditions
 Stable if stored in a well-closed container in a cool, dry place.
 Incompatibilities
 Incompatible with ferrous surface, ferric chloride, sodium citrate.
Ceratonia
 Non-proprietary Names: None adopted.
 Chemical Name : Carob gum , Ceratonia silique.
 Structural Formula:
 Functional Category:
 Controlled-release agent
 Suspending agent
 Tablet binder
 Viscosity-increasing agent
 Applications in Pharmaceutical Formulation:
 Naturally occurring materials generally used as substitute for tragacanth.
 Used as a binder, thickening agent, and stabilizing agent in the cosmetics and
food industry.
 Stability and Storage Conditions
 Stored in a well-closed container in a cool, dry place.
 Ceratonia loses not more than 15% of its weight on drying.
 Incompatibilities
 The viscosity of xanthan gum solutions is increased in the presence of ceratonia.
Ceresin
 Non-proprietary Names: None adopted.
 Chemical Name: Ceresin
 Structural Formula:
 Functional Category:
 Coating Agent
 Stabilizing agent
 Stiffening agent
 Applications in Pharmaceutical Formulation:
 Used as a stiffening agent in creams and ointments.
 Emulsion stabilizer, viscosity control agent.
 Thickener in pharmaceutical protective, topical, and vaginal creams.
 Used in cosmetics and personal care products.
 Stability and Storage Conditions
 Stored in well-closed containers in a cool, dry, well-ventilated
place, away from extreme heat and strong oxidizing agents.
 Incompatibilities
 Incompatible with strong oxidizing agents.
Cetostearyl Alcohol
 Non-proprietary Names
BP: Cetostearyl Alcohol
USP-NF: Cetostearyl Alcohol
 Structural Formula: CH3(CH2)nOH
 Functional Category
 Emollient
 Emulsifying agent
 Viscosity-increasing agent
 Applications in Pharmaceutical Formulation:
 Used in cosmetics and topical pharmaceutical preparations.
 Used in the preparation of non aqueous creams sticks, and in non lathering
shaving creams.
 Stability and Storage Conditions
 Stable under normal storage conditions.
 Stored in a well-closed container in a cool, dry place.
 Incompatibilities
 Strong oxidizing agents and metal salts.
Cetrimide
 Non-proprietary Names:
BP: Cetrimide
PhEur: Cetrimide
 Structural Formula: C19H42BrN
 Functional Category
 Antimicrobial preservative
 Antiseptic
 Cationic surfactant
 Disinfectants
 Applications in Pharmaceutical Formulation:
 Quaternary ammonium compound that is used in cosmetics and pharmaceutical
formulations as an antimicrobial preservative.
 Used as a catholic surfactant.
 Stability and Storage Conditions
 Stable in the dry state, and also in aqueous solution at ambient temperatures.
 Bulk material should be stored in a well-closed container in a cool, dry place.
 Incompatibilities
 Incompatible with soaps, anionic surfactants, high concentrations of non-ionic
surfactants. Aqueous solutions react with metals.
Cetyl Alcohol
 Non-proprietary Names:
BP: Cetyl Alcohol
USP-NF: Cetyl Alcohol
 Chemical Name: Hexadecan-1-ol
 Structural Formula: C16H34O
 Functional Category:
 Coating agent
 Emulsifying agent
 Stiffening agent
 Applications in Pharmaceutical Formulation:
 Used in cosmetics and pharmaceutical formulations such as suppositories,
modified-release solid dosage forms, emulsions, lotions, creams.
 Used for its water absorption properties in water-in-oil emulsions and ointments.
 Stability and Storage Conditions
 Stable in the presence of acids, alkalis, light, and air.
 It does not become rancid.
 Stored in a well-closed container in a cool, dry place.
 Incompatibilities
 Incompatible with strong oxidizing agents
Cetylpyridinium Chloride
 Non-proprietary Names:
BP: Cetylpyridinium Chloride
USP: Cetylpyridinium Chloride
 Chemical Name:
1-Hexadecylpyridinium chloride
 Structural Formula: C21H38ClN
 Functional Category:
 Antimicrobial preservative
 Antiseptic
 Cationic surfactant
 Disinfectant
 Solubilizing agent
 Wetting agent
 Applications in Pharmaceutical Formulation:
 Used therapeutically as an antiseptic agent.
 Mouthwashes containing cetylpyridinium chloride have been shown to inhibit
plaque formation.
 Stability and Storage Conditions
 Stable under normal conditions. It should be stored in well-closed containers.
 Incompatibilities
 Incompatible with strong oxidizing agents and bases.
Chitosan
 Non-proprietary Names
BP: Chitosan Hydrochloride
PhEur: Chitosan Hydrochloride
 Chemical Name:
Poly-b-(1,4)-2-Amino-2-deoxy-D-glucose
 Structural Formula:
 Functional Category:
 Coating agent
 Disintegrates
 Film-forming agent
 Viscosity increasing agent
 Applications in Pharmaceutical Formulation:
 Used in cosmetics and is under investigation for use in a number of
pharmaceutical formulations.
 Stability and Storage Conditions
 Stable material at room temperature, although it is hygroscopic after drying.
Stored in a tightly closed container in a cool, dry place.
 Incompatibilities
 Incompatible with strong oxidizing agents
Final weight of tablet=300 mg
API (Ciprofloxacin)=150 mg
Excipients=150 mg
Ingredients
Names
Functions Amounts (mg) Amounts (%)
Ciprofloxacin API 150 mg
Ceratonia Tablet binder 12 mg 4%
Microcrystalline Disintegrates 30 mg 10%
Na Stearate Lubricants 3 mg 1%
Cellulose acetate
phthalate
Coating agents 4.5 mg 1.5%
Cellulose acetate Diluent 100.5 mg 33.5%
Formulation of Tablet

More Related Content

What's hot

Ppt microencapsulation
Ppt microencapsulationPpt microencapsulation
Ppt microencapsulationSANA TABASSUM
 
Microsphere & microcapsules
Microsphere & microcapsulesMicrosphere & microcapsules
Microsphere & microcapsulesPravin Chinchole
 
Preformulation
PreformulationPreformulation
Preformulationlahari522
 
Drug excepients compatability studies
Drug excepients compatability studiesDrug excepients compatability studies
Drug excepients compatability studieskinju19
 
Microspheres and microcapsules
Microspheres and microcapsulesMicrospheres and microcapsules
Microspheres and microcapsulesJayBhavsar41
 
Polymers of Controlled Drug Delivery System
Polymers of Controlled Drug Delivery SystemPolymers of Controlled Drug Delivery System
Polymers of Controlled Drug Delivery SystemNabeela Moosakutty
 
Superdisintegrants in Orally Administered Products of Pharmaceuticals A Review
Superdisintegrants in Orally Administered Products of Pharmaceuticals A ReviewSuperdisintegrants in Orally Administered Products of Pharmaceuticals A Review
Superdisintegrants in Orally Administered Products of Pharmaceuticals A Reviewijtsrd
 
Fast dissolving tablets
Fast dissolving tabletsFast dissolving tablets
Fast dissolving tabletsSatyam Sharma
 
Parenteral controlled drug delivery system sushmitha
Parenteral controlled drug delivery system sushmithaParenteral controlled drug delivery system sushmitha
Parenteral controlled drug delivery system sushmithaDanish Kurien
 
Dissolution apparatus
Dissolution apparatusDissolution apparatus
Dissolution apparatusPankaj Verma
 

What's hot (20)

The systemic action of suppositories
The systemic action of suppositoriesThe systemic action of suppositories
The systemic action of suppositories
 
Solid dispersion and complexaton
Solid dispersion and complexatonSolid dispersion and complexaton
Solid dispersion and complexaton
 
Bioadhesion Drug Delivery system
Bioadhesion Drug Delivery systemBioadhesion Drug Delivery system
Bioadhesion Drug Delivery system
 
Ppt microencapsulation
Ppt microencapsulationPpt microencapsulation
Ppt microencapsulation
 
Microsphere & microcapsules
Microsphere & microcapsulesMicrosphere & microcapsules
Microsphere & microcapsules
 
Preformulation
PreformulationPreformulation
Preformulation
 
Cosolvency
CosolvencyCosolvency
Cosolvency
 
Fundamentals of modified release formulations
Fundamentals of modified release formulationsFundamentals of modified release formulations
Fundamentals of modified release formulations
 
TABLET COATING
TABLET COATINGTABLET COATING
TABLET COATING
 
Drug excepients compatability studies
Drug excepients compatability studiesDrug excepients compatability studies
Drug excepients compatability studies
 
Preformulation by Jebastin
Preformulation by JebastinPreformulation by Jebastin
Preformulation by Jebastin
 
Microspheres
MicrospheresMicrospheres
Microspheres
 
Microspheres and microcapsules
Microspheres and microcapsulesMicrospheres and microcapsules
Microspheres and microcapsules
 
Insitu gel
Insitu gelInsitu gel
Insitu gel
 
Polymers of Controlled Drug Delivery System
Polymers of Controlled Drug Delivery SystemPolymers of Controlled Drug Delivery System
Polymers of Controlled Drug Delivery System
 
Superdisintegrants in Orally Administered Products of Pharmaceuticals A Review
Superdisintegrants in Orally Administered Products of Pharmaceuticals A ReviewSuperdisintegrants in Orally Administered Products of Pharmaceuticals A Review
Superdisintegrants in Orally Administered Products of Pharmaceuticals A Review
 
Fast dissolving tablets
Fast dissolving tabletsFast dissolving tablets
Fast dissolving tablets
 
Parenterals
ParenteralsParenterals
Parenterals
 
Parenteral controlled drug delivery system sushmitha
Parenteral controlled drug delivery system sushmithaParenteral controlled drug delivery system sushmitha
Parenteral controlled drug delivery system sushmitha
 
Dissolution apparatus
Dissolution apparatusDissolution apparatus
Dissolution apparatus
 

Similar to Pharmaceutical Excipients & Formulation of a Dosage Form

Pharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxPharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxMohammadShafique24
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients Nahid Hasan
 
Formulation of parenteral preparation wps office
Formulation of parenteral preparation wps officeFormulation of parenteral preparation wps office
Formulation of parenteral preparation wps officeSudipta Roy
 
Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)SumedhGhodke
 
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxEXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxDhruv Bhavsar
 
Tablet types and Excipients
Tablet  types and ExcipientsTablet  types and Excipients
Tablet types and ExcipientsKomal Haleem
 
tablettypes-150309151055-conversion-gate01.pdf
tablettypes-150309151055-conversion-gate01.pdftablettypes-150309151055-conversion-gate01.pdf
tablettypes-150309151055-conversion-gate01.pdfSridharA50
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxSUJITHA MARY
 
Excipients.pptx asmita..
Excipients.pptx asmita..Excipients.pptx asmita..
Excipients.pptx asmita..asmitaprasad
 
Formulation Additives
Formulation AdditivesFormulation Additives
Formulation AdditivesShadab Khan
 
formulation20additives20new-200403133429 (1).pdf
formulation20additives20new-200403133429 (1).pdfformulation20additives20new-200403133429 (1).pdf
formulation20additives20new-200403133429 (1).pdfshubhanginip123
 
Pharmaceutical Emulsion and Suppository
Pharmaceutical Emulsion and Suppository     Pharmaceutical Emulsion and Suppository
Pharmaceutical Emulsion and Suppository MEHEDI HASAN
 

Similar to Pharmaceutical Excipients & Formulation of a Dosage Form (20)

Pharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxPharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptx
 
Excipients sb
Excipients sbExcipients sb
Excipients sb
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients
 
Effervscent tab
Effervscent tabEffervscent tab
Effervscent tab
 
Formulation of parenteral preparation wps office
Formulation of parenteral preparation wps officeFormulation of parenteral preparation wps office
Formulation of parenteral preparation wps office
 
Pharmaceutical Additives
Pharmaceutical AdditivesPharmaceutical Additives
Pharmaceutical Additives
 
Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)
 
Pharmaceutical Excipients
Pharmaceutical Excipients Pharmaceutical Excipients
Pharmaceutical Excipients
 
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxEXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
 
Tablet types and Excipients
Tablet  types and ExcipientsTablet  types and Excipients
Tablet types and Excipients
 
tablettypes-150309151055-conversion-gate01.pdf
tablettypes-150309151055-conversion-gate01.pdftablettypes-150309151055-conversion-gate01.pdf
tablettypes-150309151055-conversion-gate01.pdf
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptx
 
Excipients.pptx asmita..
Excipients.pptx asmita..Excipients.pptx asmita..
Excipients.pptx asmita..
 
Parenteral Products.pptx
Parenteral Products.pptxParenteral Products.pptx
Parenteral Products.pptx
 
4 vol. 5, issue 9, sep 2014, re 1332, ijpsr, paper 4
4 vol. 5, issue 9, sep 2014, re 1332, ijpsr, paper 44 vol. 5, issue 9, sep 2014, re 1332, ijpsr, paper 4
4 vol. 5, issue 9, sep 2014, re 1332, ijpsr, paper 4
 
General requirements of parenteral preparations
General requirements of parenteral preparationsGeneral requirements of parenteral preparations
General requirements of parenteral preparations
 
Formulation Additives
Formulation AdditivesFormulation Additives
Formulation Additives
 
formulation20additives20new-200403133429 (1).pdf
formulation20additives20new-200403133429 (1).pdfformulation20additives20new-200403133429 (1).pdf
formulation20additives20new-200403133429 (1).pdf
 
Pharmaceutical Emulsion and Suppository
Pharmaceutical Emulsion and Suppository     Pharmaceutical Emulsion and Suppository
Pharmaceutical Emulsion and Suppository
 

More from faysalahmed35

Niosome and Liposome
Niosome and  LiposomeNiosome and  Liposome
Niosome and Liposomefaysalahmed35
 
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...faysalahmed35
 
Factor Viii Hemophilia
Factor Viii HemophiliaFactor Viii Hemophilia
Factor Viii Hemophiliafaysalahmed35
 
Model Pharmacy and its prospect in future
Model Pharmacy and its prospect in futureModel Pharmacy and its prospect in future
Model Pharmacy and its prospect in futurefaysalahmed35
 
Tablet Coating Machine
Tablet Coating MachineTablet Coating Machine
Tablet Coating Machinefaysalahmed35
 
Basic principle of IR spectroscoy
Basic principle of IR spectroscoy Basic principle of IR spectroscoy
Basic principle of IR spectroscoy faysalahmed35
 
Oral Contraceptive Pills
Oral Contraceptive Pills Oral Contraceptive Pills
Oral Contraceptive Pills faysalahmed35
 
Genetics differences affect drug metabolism
Genetics differences affect drug metabolismGenetics differences affect drug metabolism
Genetics differences affect drug metabolismfaysalahmed35
 
Sedative & Hypnotics ppt
Sedative & Hypnotics pptSedative & Hypnotics ppt
Sedative & Hypnotics pptfaysalahmed35
 
pharmaceutical suspension-ppt
pharmaceutical suspension-pptpharmaceutical suspension-ppt
pharmaceutical suspension-pptfaysalahmed35
 
High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)faysalahmed35
 
Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)faysalahmed35
 

More from faysalahmed35 (15)

Niosome and Liposome
Niosome and  LiposomeNiosome and  Liposome
Niosome and Liposome
 
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
 
Albendazole Tablet
Albendazole TabletAlbendazole Tablet
Albendazole Tablet
 
Factor Viii Hemophilia
Factor Viii HemophiliaFactor Viii Hemophilia
Factor Viii Hemophilia
 
Penicillin
PenicillinPenicillin
Penicillin
 
Model Pharmacy and its prospect in future
Model Pharmacy and its prospect in futureModel Pharmacy and its prospect in future
Model Pharmacy and its prospect in future
 
Tablet Coating Machine
Tablet Coating MachineTablet Coating Machine
Tablet Coating Machine
 
Hypertension
Hypertension Hypertension
Hypertension
 
Basic principle of IR spectroscoy
Basic principle of IR spectroscoy Basic principle of IR spectroscoy
Basic principle of IR spectroscoy
 
Oral Contraceptive Pills
Oral Contraceptive Pills Oral Contraceptive Pills
Oral Contraceptive Pills
 
Genetics differences affect drug metabolism
Genetics differences affect drug metabolismGenetics differences affect drug metabolism
Genetics differences affect drug metabolism
 
Sedative & Hypnotics ppt
Sedative & Hypnotics pptSedative & Hypnotics ppt
Sedative & Hypnotics ppt
 
pharmaceutical suspension-ppt
pharmaceutical suspension-pptpharmaceutical suspension-ppt
pharmaceutical suspension-ppt
 
High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)
 
Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)
 

Recently uploaded

18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxEyham Joco
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.arsicmarija21
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Recently uploaded (20)

18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Types of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptxTypes of Journalistic Writing Grade 8.pptx
Types of Journalistic Writing Grade 8.pptx
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.AmericanHighSchoolsprezentacijaoskolama.
AmericanHighSchoolsprezentacijaoskolama.
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 

Pharmaceutical Excipients & Formulation of a Dosage Form

  • 1. Pharmaceutical Excipients & Formulation of a Dosage Form Presented by Md. Faysal Id: 151-29-760
  • 2. Cellulose acetate  Non-proprietary name: BP : Cellulose acetate USP : Cellulose acetate  Chemical name: Cellulose acetate , Cellulose diacetate , Cellulose triacetate.  Structure formula: C164H174O111  Functional category:  Coating agent  Extended release agent  Tablet and capsule diluent
  • 3.  Application in pharmaceutical formulation:  Used as a semipermeable coating on tablets.  Used in transdermal drug delivery systems.  Highly absorbent and resistant to moderate temperature.  They don’t shrink or wrinkle.  Stability and storage conditions:  Stable if stored in a well-closed container in a cool, dry place .  Incompatibilities:  Incompatible with strongly acidic or alkaline substances.
  • 4. Cellulose Acetate Phthalate  Non-proprietary Name: BP: Cellacefate USP: Cellacefate  Chemical Name: Cellulose, acetate, 1,2-benzenedicarboxylate  Structural Formula:  Functional Category : Coating agent
  • 5.  Applications in Pharmaceutical Formulation:  Used as an enteric film coating material.  Used as a matrix binder for tablets and capsules.  Commonly applied to solid-dosage forms.  Stability and Storage Conditions  Stable if stored in a well-closed container in a cool, dry place.  Incompatibilities  Incompatible with ferrous surface, ferric chloride, sodium citrate.
  • 6. Ceratonia  Non-proprietary Names: None adopted.  Chemical Name : Carob gum , Ceratonia silique.  Structural Formula:  Functional Category:  Controlled-release agent  Suspending agent  Tablet binder  Viscosity-increasing agent
  • 7.  Applications in Pharmaceutical Formulation:  Naturally occurring materials generally used as substitute for tragacanth.  Used as a binder, thickening agent, and stabilizing agent in the cosmetics and food industry.  Stability and Storage Conditions  Stored in a well-closed container in a cool, dry place.  Ceratonia loses not more than 15% of its weight on drying.  Incompatibilities  The viscosity of xanthan gum solutions is increased in the presence of ceratonia.
  • 8. Ceresin  Non-proprietary Names: None adopted.  Chemical Name: Ceresin  Structural Formula:  Functional Category:  Coating Agent  Stabilizing agent  Stiffening agent
  • 9.  Applications in Pharmaceutical Formulation:  Used as a stiffening agent in creams and ointments.  Emulsion stabilizer, viscosity control agent.  Thickener in pharmaceutical protective, topical, and vaginal creams.  Used in cosmetics and personal care products.  Stability and Storage Conditions  Stored in well-closed containers in a cool, dry, well-ventilated place, away from extreme heat and strong oxidizing agents.  Incompatibilities  Incompatible with strong oxidizing agents.
  • 10. Cetostearyl Alcohol  Non-proprietary Names BP: Cetostearyl Alcohol USP-NF: Cetostearyl Alcohol  Structural Formula: CH3(CH2)nOH  Functional Category  Emollient  Emulsifying agent  Viscosity-increasing agent
  • 11.  Applications in Pharmaceutical Formulation:  Used in cosmetics and topical pharmaceutical preparations.  Used in the preparation of non aqueous creams sticks, and in non lathering shaving creams.  Stability and Storage Conditions  Stable under normal storage conditions.  Stored in a well-closed container in a cool, dry place.  Incompatibilities  Strong oxidizing agents and metal salts.
  • 12. Cetrimide  Non-proprietary Names: BP: Cetrimide PhEur: Cetrimide  Structural Formula: C19H42BrN  Functional Category  Antimicrobial preservative  Antiseptic  Cationic surfactant  Disinfectants
  • 13.  Applications in Pharmaceutical Formulation:  Quaternary ammonium compound that is used in cosmetics and pharmaceutical formulations as an antimicrobial preservative.  Used as a catholic surfactant.  Stability and Storage Conditions  Stable in the dry state, and also in aqueous solution at ambient temperatures.  Bulk material should be stored in a well-closed container in a cool, dry place.  Incompatibilities  Incompatible with soaps, anionic surfactants, high concentrations of non-ionic surfactants. Aqueous solutions react with metals.
  • 14. Cetyl Alcohol  Non-proprietary Names: BP: Cetyl Alcohol USP-NF: Cetyl Alcohol  Chemical Name: Hexadecan-1-ol  Structural Formula: C16H34O  Functional Category:  Coating agent  Emulsifying agent  Stiffening agent
  • 15.  Applications in Pharmaceutical Formulation:  Used in cosmetics and pharmaceutical formulations such as suppositories, modified-release solid dosage forms, emulsions, lotions, creams.  Used for its water absorption properties in water-in-oil emulsions and ointments.  Stability and Storage Conditions  Stable in the presence of acids, alkalis, light, and air.  It does not become rancid.  Stored in a well-closed container in a cool, dry place.  Incompatibilities  Incompatible with strong oxidizing agents
  • 16. Cetylpyridinium Chloride  Non-proprietary Names: BP: Cetylpyridinium Chloride USP: Cetylpyridinium Chloride  Chemical Name: 1-Hexadecylpyridinium chloride  Structural Formula: C21H38ClN  Functional Category:  Antimicrobial preservative  Antiseptic  Cationic surfactant  Disinfectant  Solubilizing agent  Wetting agent
  • 17.  Applications in Pharmaceutical Formulation:  Used therapeutically as an antiseptic agent.  Mouthwashes containing cetylpyridinium chloride have been shown to inhibit plaque formation.  Stability and Storage Conditions  Stable under normal conditions. It should be stored in well-closed containers.  Incompatibilities  Incompatible with strong oxidizing agents and bases.
  • 18. Chitosan  Non-proprietary Names BP: Chitosan Hydrochloride PhEur: Chitosan Hydrochloride  Chemical Name: Poly-b-(1,4)-2-Amino-2-deoxy-D-glucose  Structural Formula:  Functional Category:  Coating agent  Disintegrates  Film-forming agent  Viscosity increasing agent
  • 19.  Applications in Pharmaceutical Formulation:  Used in cosmetics and is under investigation for use in a number of pharmaceutical formulations.  Stability and Storage Conditions  Stable material at room temperature, although it is hygroscopic after drying. Stored in a tightly closed container in a cool, dry place.  Incompatibilities  Incompatible with strong oxidizing agents
  • 20. Final weight of tablet=300 mg API (Ciprofloxacin)=150 mg Excipients=150 mg Ingredients Names Functions Amounts (mg) Amounts (%) Ciprofloxacin API 150 mg Ceratonia Tablet binder 12 mg 4% Microcrystalline Disintegrates 30 mg 10% Na Stearate Lubricants 3 mg 1% Cellulose acetate phthalate Coating agents 4.5 mg 1.5% Cellulose acetate Diluent 100.5 mg 33.5% Formulation of Tablet